Page results
-
UCLH has recruited the first patient in Europe for an early phase trial of a potential new medicine for patients that have a specific sub-type of multiple myeloma (MM), a type of bone marrow cancer.
-
The diabetes team have revisited their tips for managing diabetes over the Christmas holidays and updated them for 2022.
-
On Saturday 25 June 2022, UCLH partnered with North Middlesex University Hospital and Whittington Health to run a summer sickle cell event at Tottenham Hotspur Stadium for children and young people with sickle cell disorder.
-
Information about the Therapeutic Plasma Exchange at NHNN for patients, carers, and families.
-
Nine Covid-19 research studies are already taking place at UCLH and the Trust is processing more than 30 study proposals as research efforts around the virus and pandemic are ramped up.
-
This page has been written by the team in the mitochondrial clinic for patients who are seen at the National Hospital for Neurology and Neurosurgery, who have a diagnosis of mitochondrial disease.
-
Holistic Needs Assessment (HNA): Information for people affected by cancer and blood conditions patient information leaflet
-
Read more about the NHS Staff Survey 2024 - we’re the top acute trust to work at for third year running!
-
Trial of T-cell therapy for lung cancer begins at UCLH
-
RESPOND – Information for healthcare professionals and services working with asylum seekers
File results
-
FOI/2023/0195 - Patient level costing system and integrated data platform
-
FOI/2023/0192 - Non emergency patient transport - NEPTS and taxi procurement
-
FOI/2023/0187 - Treatment for urothelial and colorectal cancer
-
FOI/2023/0182 - Data privacy compliance tools
-
FOI/2023/0180 - Treatment guidelines for chronic kidney disease/ diabetic kidney disease
-
FOI/2023/0175 - Treatment for Myelofibrosis
-
FOI/2023/0174 - Integration Engine (IE) within Trust's IT estate
-
FOI/2023/0162 - ICT and Procurement strategy and organisational charts
-
FOI/2023/0132 - Renal cell carcinoma and melanoma treatment
-
FOI/2023/0139 - Meningitis and Encephalitis guidelines/ pathway